Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy

30 Aug 2024

Abstract excerpt

Induced pluripotent stem cells (iPSCs) have emerged as a revolutionary tool in cell therapies due to their ability to differentiate into various cell types, unlimited supply, and potential as off-the-shelf cell products. New advances in iPSC-derived immune cells have generated potent iNK and iT cells which showed robust killing of cancer cells in animal models and clinical trials. With the advent of advanced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to RNA Interference and Gene Delivery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39281684
DOI: 10.3389/fimmu.2024.1457629

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapyPMID 39281684Read ↗

From induced pluripotent stem cell (iPSC) to universal immune cells: literature review of advances in a new generation of tumor therapiesSemantic proximity Read ↗

Engineered and banked iPSCs for advanced NK- and T-cell immunotherapiesSemantic proximity Read ↗

Multiplexed iPSC platform for advanced NK cell immunotherapiesSemantic proximity Read ↗

Induced Pluripotent Stem Cell (iPSC)–Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and ChallengesSemantic proximity Read ↗

Engineering the next generation of allogeneic CAR cells: iPSCs as a scalable and editable platformSemantic proximity Read ↗

Engineered T cells from induced pluripotent stem cells: from research towards clinical implementationSemantic proximity Read ↗

Genome editing iPSC to purposing enhancement of induce CD8 killer T cell function for regenerative immunotherapySemantic proximity Read ↗

Emerging Cellular Therapies for CancerSemantic proximity Read ↗

Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cellsSemantic proximity Read ↗

Advancing cell-based cancer immunotherapy through stem cell engineeringSemantic proximity Read ↗

Induced Pluripotent Stem Cell-Based Cancer Immunotherapy: Strategies and PerspectivesSemantic proximity Read ↗

Pluripotent stem cell-based immunotherapy: advances in translational research, cell differentiation, and gene modificationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.